Subscribe To
Gilead sciences told by fda to pause patient enrollment in leukemia drug trials
Gilead Sciences, Inc. (NASDAQ:GILD) said the Food and Drug Administration (FDA) has put a clinical hold on its studies evaluating its investigation an...
August 21, 2023, 10:41 am
Atopic dermatitis market to reach us$ 62.7 billion, with double digit cagr of 24% | fact.mr
[Updated Report 2022-2032] Atopic Dermatitis Market Analysis By Drug Class (Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI ...
August 18, 2023, 7:07 am
Excision biotherapeutics announces gene therapy publication of pre-clinical data supporting its first-in-class crispr-based gene therapy candidate designed to functionally cure hiv-1
Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SI...
August 17, 2023, 11:30 am
Roivant sciences earnings come in below street estimates despite vtama sales growth
Roivant Sciences shares traded modestly higher after the inflammation and immunology-focused biopharmac...
August 14, 2023, 10:47 am
immunovant (imvt) q1 loss wider y/y, pipeline in focus
immunovant's (IMVT) reports wider-than-expected loss for fiscal first-quarter 2023. IMVT is on track wi...
August 11, 2023, 1:03 pm
Aim immunotech to discuss second quarter 2023 financial results on august 15, 2023, and host conference call and webcast
OCALA, Fla., Aug. 09, 2023 (GLOBE NEWSWIRE) — AIM immunoTech Inc. (NYSE American: AIM) (“AIM” or ...
August 9, 2023, 1:05 pm
Aim immunotech to discuss second quarter 2023 financial results on august 15, 2023, and host conference call and webcast
OCALA, Fla., Aug. 09, 2023 (GLOBE NEWSWIRE) -- AIM immunoTech Inc. (NYSE American: AIM) (“AIM” or t...
August 9, 2023, 9:05 am
Hillstream biopharma to present at the sidoti micro-cap virtual conference on august 16-17, 2023
BRIDGEWATER, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology compan...
August 9, 2023, 8:47 am
Options bears break bank with biotech stock puts
Subscribers to Schaeffer's Event Trader service scored a 272% profit with our immunoGen, Inc. (NASD...
August 8, 2023, 3:11 pm
Aim immunotech announces completion of enrollment in phase 2 study evaluating ampligen® for the treatment of post-covid conditions
Topline data expected as early as Q1 2024 OCALA, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) — AIM immunoTec...
August 8, 2023, 12:05 pm
Galapagos nv (glpg) q2 2023 earnings call transcript
Galapagos NV (NASDAQ:GLPG ) Q2 2023 Results Conference Call August 4, 2023 8:00 AM ET Company Participants Sofie Van Gijsel - Head, IR Paul Stoffels -...
August 4, 2023, 4:30 pm
Biontech: unraveling a bargain, a hidden opportunity in market misjudgments
A leading immunotherapy innovator with a focus on oncology and infectious diseases. With a strong pipel...
August 4, 2023, 3:27 am
Why coherus biosciences stock popped today
The immuno-oncology biotech specialist delivered stronger-than-expected revenue and earnings in Q2. Coh...
August 3, 2023, 7:43 pm
Hookipa pharma to report second quarter 2023 financial results and recent business highlights on august 10, 2023
NEW YORK and VIENNA, Austria, Aug. 03, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class o...
August 3, 2023, 11:01 am
immunocore to report second quarter 2023 financial results and host call on august 10, 2023
immunocore to report second quarter 2023 financial results and host call on August 10, 2023...
August 3, 2023, 8:00 am
Hookipa pharma to report second quarter 2023 financial results and recent business highlights on august 10, 2023
NEW YORK and VIENNA, Austria, Aug. 03, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA'), a company developing a new class of <...
August 3, 2023, 7:01 am
Affimed to report second quarter 2023 financial results & corporate update on august 10, 2023
HEIDELBERG, Germany, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno...
August 3, 2023, 6:30 am
Ocean biomedical, inc. (nasdaq: ocea) celebrates 95% lung cancer tumor reduction results on world lung cancer day
Ocean Biomedical's Oncology Platform currently consists of 27 Patents Issued or Pending. Ocean Biomedical's first-in-class anti-CHi3L1 therapeutic
August 1, 2023, 8:01 am
Merck posts narrower-than-expected loss as sales of top drugs beat street estimates
Merck & Co posted narrower-than-expected second-quarter loss and raised its full-year profit forecast on Tuesday on the strength of its two top-sellin...
August 1, 2023, 6:37 am
Bolt biotherapeutics to present at btig virtual biotechnology conference 2023
REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing no...
July 31, 2023, 9:27 pm